Clinical Trials · NCT01595789
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Haugaard, Steen Bendix, M.D., DMSc
- Enrollment
- 41
- Start date
- May 2012
- Locations
- 1 site, Denmark
- Primary endpoint
- Beta-cell function